These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9580318)

  • 1. The course of relapse across 36 months for smokers from a smoking-cessation program.
    Becoña E; Vázquez FL
    Psychol Rep; 1998 Feb; 82(1):143-6. PubMed ID: 9580318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does using relapse prevention increase the efficacy of a program for smoking cessation?: An empirical study.
    Becoña E; Vázquez FL
    Psychol Rep; 1997 Aug; 81(1):291-6. PubMed ID: 9293218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing smoking cessation rates in primary care.
    Wadland WC; Stöffelmayr B; Berger E; Crombach A; Ives K
    J Fam Pract; 1999 Sep; 48(9):711-8. PubMed ID: 10498078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of a cognitive-behavioral program with pharmacological support to achieve smoking cessation].
    Felten D; Raupach T; Sessler C; Lüthje L; Hasenfuss G; Andreas S
    Dtsch Med Wochenschr; 2006 Feb; 131(5):197-202. PubMed ID: 16440265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial.
    Fu SS; van Ryn M; Sherman SE; Burgess DJ; Noorbaloochi S; Clothier B; Taylor BC; Schlede CM; Burke RS; Joseph AM
    JAMA Intern Med; 2014 May; 174(5):671-7. PubMed ID: 24615217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alternative five-factor model of personality, nicotine dependence and relapse after treatment for smoking cessation.
    Nieva G; Valero S; Bruguera E; Andión Ó; Trasovares MV; Gual A; Casas M
    Addict Behav; 2011 Oct; 36(10):965-71. PubMed ID: 21704460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
    Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
    Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for tobacco consumption reduction after relapse.
    Morchon S; Masuet C; Ramon JM
    Addict Behav; 2007 Sep; 32(9):1877-86. PubMed ID: 17321692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation and its predictors: results from a community-based pharmacy tobacco cessation program in New Mexico.
    Khan N; Anderson JR; Du J; Tinker D; Bachyrycz AM; Namdar R
    Ann Pharmacother; 2012 Sep; 46(9):1198-204. PubMed ID: 22911338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study.
    Schäfer J; Young J; Bernasconi E; Ledergerber B; Nicca D; Calmy A; Cavassini M; Furrer H; Battegay M; Bucher H;
    HIV Med; 2015 Jan; 16(1):3-14. PubMed ID: 24809704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trajectories of cigarettes per day during the course of telephone tobacco cessation counseling services: a comparison of missing data models.
    Witkiewitz K; Bush T; Magnusson LB; Carlini BH; Zbikowski SM
    Nicotine Tob Res; 2012 Sep; 14(9):1100-4. PubMed ID: 22180594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
    Croghan IT; Hurt RD; Dakhil SR; Croghan GA; Sloan JA; Novotny PJ; Rowland KM; Bernath A; Loots ML; Le-Lindqwister NA; Tschetter LK; Garneau SC; Flynn KA; Ebbert LP; Wender DB; Loprinzi CL
    Mayo Clin Proc; 2007 Feb; 82(2):186-95. PubMed ID: 17290726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulsivity and smoking relapse.
    Doran N; Spring B; McChargue D; Pergadia M; Richmond M
    Nicotine Tob Res; 2004 Aug; 6(4):641-7. PubMed ID: 15370160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the application of the American Diabetes Association guidelines regarding tobacco dependency in subjects with diabetes mellitus.
    Albareda M; Sánchez L; González J; Viguera J; Mestrón A; Vernet A; Vila L
    Metabolism; 2009 Sep; 58(9):1234-8. PubMed ID: 19481770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Delay Discounting and Other Predictors on Smoking Relapse.
    González-Roz A; Secades-Villa R; Pericot-Valverde I; Weidberg S; Alonso-Pérez F
    Span J Psychol; 2019 Mar; 22():E9. PubMed ID: 30885283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Smoking cessation program in Tunisia: experience of a respiratory service].
    Aouina H; El Gharbi L; Fakhfakh R; Aissa I; Azzabi S; Baccar MA; Bouach H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1123-7. PubMed ID: 12546123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing and risk factors associated with relapse among smokers attempting to quit in Malaysia.
    Yasin SM; Moy FM; Retneswari M; Isahak M; Koh D
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):980-5. PubMed ID: 22507850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of predictors of nicotine abstinence in a smoking cessation treatment study of smokers with a past history of alcohol dependence.
    Kalman D; Tirch D; Penk W; Denison H
    Psychol Addict Behav; 2002 Dec; 16(4):346-9. PubMed ID: 12503909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse to smoking.
    Piasecki TM
    Clin Psychol Rev; 2006 Mar; 26(2):196-215. PubMed ID: 16352382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of smoking cessation counseling after myocardial infarction.
    Dornelas EA; Sampson RA; Gray JF; Waters D; Thompson PD
    Prev Med; 2000 Apr; 30(4):261-8. PubMed ID: 10731452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.